Among patients with disabling strokes without medium or large occlusions, more of those taking tirofiban had good function at 90 days than those on aspirin, results of the RESCUE BT2 trial show.
A new study provides evidence for better functional recovery after endovascular therapy from a population of large-infarction strokes that could contribute to changing clinical practice.
THURSDAY, Oct. 13, 2022 (HealthDay News) For patients with basilar-artery occlusion, a greater percentage with good functional status at 90 days is seen with endovascular thrombectomy within 12 hours after stroke, or within six and 24 hours after stroke onset, compared with medical therapy only, according to two studies published in the Oct. 13